Can Stem Cell Therapy Help with Glaucoma, Macular Degeneration and Other Eye Diseases?

Stem cell research is transforming the field of vision care and bringing fresh hope to those affected by a wide variety of eye conditions. Scientists are making strides in everything from restoring sight for people with corneal damage to finding new ways to replace or repair cells lost to diseases like macular degeneration and glaucoma. Although most of these treatments are still being tested, the advances so far are both promising and inspiring. In this article, we explore how stem cell therapy works for various eye conditions, highlight the different types of stem cells used in vision research, and summarize the latest breakthroughs for diseases such as age-related macular degeneration, glaucoma, and dry eye syndrome. We also touch on the important considerations and safety issues involved with these emerging treatments. And, we share practical lifestyle tips that can support your eye health alongside the latest scientific advances.

What are Stem Cells?

Stem cells are undifferentiated cells, meaning they don’t have a specialized function—yet! Stem cells are extraordinary because they can differentiate into many specialized cell types, playing a vital role in growth, healing, and tissue repair. We find them naturally in embryos and in some adult tissues, such as bone marrow, fat, and the eyes. They support the body’s ability to recover and regenerate after injury. In addition to these natural sources, scientists can also create stem cells in the lab by reprogramming ordinary adult cells—such as those from the skin or blood—into induced pluripotent stem cells (iPSCs), which behave much like embryonic stem cells. This versatility in both function and sourcing is what makes stem cells so valuable for advancing research and developing new therapies, especially for conditions that currently have limited treatment options.

How Stem Cell Therapy Works for Eye Diseases

Cell replacement: Stem cells can be used to grow into specific eye cells, such as photoreceptors or retinal pigment epithelial (RPE) cells, and then transplanted to replace damaged or lost cells. Neuroprotection: Stem cells can be injected to release growth factors and other proteins that protect existing, compromised retinal cells from further damage. Tissue repair: For corneal damage, stem cells from a healthy part of the eye can be cultivated and transplanted to repair the damaged cornea. Dry eye treatment: Stem cells may help regenerate the tear film, reduce inflammation, and improve the function of tear-producing glands.

Types of Stem Cells in Vision Science

Embryonic stem cells (ESCs) have the remarkable ability to become any cell type in the body, which is why they are so important in regenerative medicine and eye health research. Induced pluripotent stem cells (iPSCs) start out as regular adult cells, but scientists have found ways to reprogram them so they act much like embryonic stem cells. This gives iPSCs a similar potential for developing new therapies and treatments. Adult Stem Cells: Present in limited quantities throughout the body, these cells can develop into a select range of specialized cells. For example, bone marrow stem cells generate blood and immune cells, while corneal limbal stem cells assist in eye surface repair. The retina also contains a type called retinal progenitor cells. Although these cells don’t typically replace damaged retinal cells naturally, researchers have found ways to coax them into producing new retinal cells in laboratory settings. While adult stem cells are under investigation for treating severe eye conditions, their regenerative potential is generally more restricted than that of ESCs or iPSCs.

Age-Related Macular Degeneration (AMD)

In a study published in Cell Stem Cell, patients with advanced dry AMD received transplants of specialized stem cells originally sourced from eye bank tissue. These adult stem cells were limited in function and could only mature into retinal pigment epithelial cells.¹ In the early stages of AMD, retinal pigment epithelial cells begin to function incorrectly. In more advanced stages of AMD, they start to become unable to regenerate. A first-of-its-kind trial is testing adult stem cell transplants for advanced dry macular degeneration. Early results show the treatment is safe and can significantly improve vision, even in severely affected patients. Participants gained measurable improvements in sight in the treated eye. Researchers are now monitoring higher-dose groups as the therapy advances toward later trial phases. This study followed 6 patients, so further studies with a larger population are needed to confirm the results and improve methods.

Corneal Restoration

In Japan, a new approach using donor iPS-cell-derived transplants has restored vision in patients with corneal scarring and vision impairment due to the depletion of their natural cornea-building stem cells.²

Glaucoma

Stem cell therapy is emerging as a promising experimental approach for glaucoma, a condition where damage to retinal ganglion cells (RGCs) leads to progressive vision loss. Current research is investigating whether stem cells—especially induced pluripotent stem cells (iPSCs) and mesenchymal stem cells—can be used to replace or regenerate these damaged RGCs. Early lab and animal studies have shown that transplanted stem cells can survive in the eye, integrate with existing retinal tissue, and in some cases, even promote the survival or repair of native ganglion cells by releasing protective growth factors. However, this field is still in its early stages. Scientists are working to overcome challenges, such as ensuring that the new cells function properly and connect to the optic nerve. While stem cell therapy for glaucoma is not available outside of clinical trials yet, ongoing research continues to offer hope for future regenerative treatments.³

Dry Eyes

Recent research is showing promising results for stem cell therapy as a new approach to treating dry eye disease. Traditional treatments focus primarily on symptom relief. However, stem cell-based therapies—particularly those using mesenchymal stem cells (MSCs)—are being studied for their ability to repair and regenerate the tissues that produce and maintain a healthy tear film. Early studies in animal models and small-scale human trials have found that MSCs can help increase the number of conjunctival goblet cells, reduce inflammation, and promote healing of the ocular surface.⁴ These are all key to restoring natural tear production and improving overall eye comfort. While these treatments are still experimental and not yet widely available, they offer hope for people with severe or treatment-resistant dry eye syndrome.

Retinal Pigment Epithelium (RPE)

When retinal pigment epithelium (RPE) cells are damaged or lost, the photoreceptors they support begin to break down—a process that plays a major role in age-related macular degeneration (AMD) and some types of retinitis pigmentosa (RP). Researchers are now exploring how human embryonic stem cells (hESCs) can be used to create a steady supply of healthy RPE cells for transplantation, opening the door to new treatment possibilities for these serious eye diseases. The deterioration and loss of RPE cells are central to the progression of disorders like Best Disease, various types of retinitis pigmentosa, and especially age-related macular degeneration—the most common cause of severe vision loss in Western countries.

Parkinson’s Disease

Two new clinical trials have shown promising results for stem cell therapy in patients with Parkinson’s disease. They found improved motor symptoms and increased dopamine activity after stem cell-derived progenitor cell transplants.⁵

Important Considerations

Current status: Most stem cell treatments for eye diseases are still experimental and are being tested in clinical trials. Safety and effectiveness: There are risks involved, such as infection or inflammation, and patients should be cautious of unlicensed clinics and treatments that are not part of a properly regulated clinical trial.

What You Can Do

Plenty of peer-reviewed studies show that healthy habits—like eating well, staying active, managing stress, getting enough sleep, and using the right supplements—can help lower your risk of developing eye diseases and support vision for those already dealing with conditions such as Macular Degeneration, Glaucoma, Retinitis Pigmentosa, Dry Eye Syndrome, Cataracts, and others. If you’re interested in learning more, you’ll find lots of helpful articles and research summaries on our blog. We are also available by phone and email with any questions you may have at 845-475-4158 and [email protected].